NTTGUIDE

Cefepime

Effect of ECMO Minimal impact on drug PK
Dose recommendation ECMO-specific dose adjustment not required
Comments, reference Dosing should be guided mainly by renal function and use of concurrent CRRT.
Consider extended infusion + therapeutic drug monitoring (if available) in patients with augmented renal clearance (CrCl >130). Ref: Clin Pharmacokinet 2026;65:193.

An unhandled error has occurred. Reload 🗙

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please reload the page.